CoChat

Age-Related Adaptive Immune Changes in Parkinson’s Disease

Open access
Kouli, Antonina, Williams-Gray, Caroline H. · 2022 · Journal of Parkinson's Disease

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.

Abstract

Ageing is a major risk factor for most neurodegenerative diseases, including Parkinson’s disease (PD). Progressive age-related dysregulation of the immune system is termed immunosenescence and is responsible for the weakened response to novel antigens, increased susceptibility to infections and reduced effectiveness of vaccines seen in the elderly. Immune activation, both within the brain and periphery, is heavily implicated in PD but the role of immunosenescence has not been fully explored. Studies to date provide some evidence for an attenuation in immunosenescence in PD, particularly a reduction in senescent CD8 T lymphocytes in PD cases compared to similarly aged controls. Here, we discuss recent evidence of age-related immune abnormalities in PD with a focus on T cell senescence and explore their potential role in disease pathogenesis and development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jpd-223228

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic illustration showing a hypothesized relationship between immunosenescence and Parkinson’s disease risk/progression. With advancing age there is progressive decline in the size and function of the thymus gland (thymic involution), as well as increased exposure to viruses such as cytomegalovirus. This leads to immunosenescence, characterized by a reduction in antigen-inexperienced naïve T cells and an increase in “senescent” terminally differentiated effector T cells (TEMRA). The senescent shift is associated with a weakened immune response to novel antigens. However, in people who are predisposed to develop Parkinson’s disease, the typical age-associated shift towards senescence in the CD8 T cell population may be attenuated, with a reduced accumulation of CD8 TEMRA T cells in these individuals. This could lead to a heightened immune response to newly encountered antigens (such as misfolded alpha-synuclein), thereby increasing the risk of developing Parkinson’s and/or promoting more rapid disease progression. CMV, Cytomegalovirus; PD, Parkinson’s disease.
Fig. 1 Schematic illustration showing a hypothesized relationship between immunosenescence and Parkinson’s disease risk/progression. With advancing age there is progressive decline in the size and function of the thymus gland (thymic involution), as well as increased exposure to viruses such as cytomegalovirus. This leads to immunosenescence, characterized by a reduction in antigen-inexperienced naïve T cells and an increase in “senescent” terminally differentiated effector T cells (TEMRA). The senescent shift is associated with a weakened immune response to novel antigens. However, in people who are predisposed to develop Parkinson’s disease, the typical age-associated shift towards senescence in the CD8 T cell population may be attenuated, with a reduced accumulation of CD8 TEMRA T cells in these individuals. This could lead to a heightened immune response to newly encountered antigens (such as misfolded alpha-synuclein), thereby increasing the risk of developing Parkinson’s and/or promoting more rapid disease progression. CMV, Cytomegalovirus; PD, Parkinson’s disease.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 25

Metadata

Authors
Kouli, A., & Williams-Gray, C. H.
Affiliations
  • University of Cambridge (GB)
  • Department of Clinical Neurosciences, University of Cambridge, John Van Geest Centre for Brain Repair, Cambridge, UK
Corresponding author
Kouli, Antonina
Venue
Journal of Parkinson's Disease
Published
2022-09-27
Volume
12
Issue
s1
Pages
S93-S104
ISSN
  • 1877-7171 (ISSN-L)
  • 1877-718X
OpenAlex
W4281741142
Cited by
20
References
94
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 2 · 2022: 1
FWCI
0.76
Type
journal article
Language
en
Open access
Locations
  • Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
  • Apollo (cc-by)
Funders
  • UK Research and Innovation
  • National Institute for Health and Care Research ([IS-BRC-1215-20014, BRC1215-20014)
  • Research Councils UK
  • Medical Research Council (MR/R007446/1, BRC-1215-20014)
  • NIHR Cambridge Biomedical Research Centre ((BRC-1215-20014))
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
Parkinson's disease, immunosenescence, age-related immune changes, T cell senescence, CD8+ T cells, neuroinflammation, neurodegeneration, pathogenesis
MeSH terms
Immunosenescence, Aged, Aging, Humans, Parkinson Disease, T-Lymphocytes, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.